Blood Glucose monitoring systems Market: Facts, Figures and Analytical Insights 2021-2030

The Blood Glucose monitoring systems Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of COVID-19 (Corona Virus) on the product industry chain based on the upstream and downstream markets, on various regions and major countries and on the future development of the industry are pointed out.

Click the link to get a Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/01162550863/blood-glucose-monitoring-systems-market-insights-competitive-landscape-and-market-forecast-2025/inquiry?Mode=12      

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Blood Glucose monitoring systems Market: Abbott Laboratories , ARKRAY, Inc., Bayer AG , Dexcom, Inc. , F. Hoffmann-La Roche Ltd, Johnson & Johnson , Medtronic plc , Nipro Diagnostics, Inc., and Terumo Medical Corporation and others. 

Industry News and Updates:

FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes

June 21, 2018: The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the first FDA-approved CGM system to include a fully implantable sensor to detect glucose, which can be worn for up to 90 days.

People with diabetes either do not make enough insulin (type 1 diabetes) or cannot use insulin properly (type 2 diabetes). When the body does not have enough insulin, or cannot use it effectively, sugar builds up in the blood. High blood sugar levels can lead to heart disease, stroke, blindness, kidney failure and amputation of toes, feet or legs. Individuals living with diabetes must regularly monitor their glucose levels as part of the management of the disease. This includes making sure that diabetes management accessories, like most current glucose sensors, are replaced on a regular basis (generally, every seven days) to ensure that an overall CGM system is properly functioning.

The Eversense CGM system uses a small sensor that is implanted just under the skin by a qualified health care provider during an outpatient procedure. After it is implanted, the sensor regularly measures glucose levels in adults with diabetes for up to 90 days. The implanted sensor works with a novel light-based technology to measure glucose levels and send information to a mobile app to alert users if glucose levels are too high (hyperglycemia) or too low (hypoglycemia). The sensor is coated with a fluorescent chemical which, when exposed to blood sugar, produces a small amount of light that is measured by the sensor. Every five minutes, measurements are sent to a compatible mobile device (e.g., smart phone or tablet) that is running a device-specific mobile app.

FDA clears next-generation integrated continuous glucose monitor

June 15, 2020: The FDA has cleared a next-generation integrated continuous glucose monitoring system for adults and children aged 4 years and older with diabetes, according to a press release from Abbott.

The FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system is the only system with optional, real-time alarms that measure glucose levels every minute. The system has a 14-day wear time, making it the longest-lasting, self-applied iCGM available, according to the release.

According to the FDA, an iCGM can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. In the release, Abbott states this system must not be used with an automated insulin dosing system, such as a closed-loop insulin delivery system, and insulin suspend systems.

Overview:

The quantity of sugar present in the blood sample is determined by a small instrument called a glucose metre or glucometer.The main factors driving this market's growth are the global increase in the prevalence and occurrence of diabetes and the growing implementation of continuous glucose monitoring (CGM) systems. Moreover, ongoing technical developments in the ageing population are further stimulating the market. However some of the main factors hindering the development of this business are insufficient compensation and high costs associated with the application of continuous glucose monitoring systems and product recalls.

Influence Of The Blood Glucose monitoring systems Market Report:

-Comprehensive assessment of all opportunities and risk in the Blood Glucose monitoring systems market.

- Blood Glucose monitoring systems market recent innovations and major events.

-A Detailed study of business strategies for growth of the Blood Glucose monitoring systems market-leading players.

-Conclusive study about the growth plot of Blood Glucose monitoring systems market for forthcoming years.

-In-depth understanding of Blood Glucose monitoring systems market-particular drivers, constraints and major micro markets.

-Favorable impression inside vital technological and market latest trends striking the Blood Glucose monitoring systems market.

Buy This Report:

https://www.marketinsightsreports.com/report/purchase/01162550863?mode=su?Mode=12      

What Are The Market Factors That Are Explained In The Report?

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Analytical Tools: The Global Blood Glucose monitoring systems Market Report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

The report has 150 tables and figures browse the report description and TOC:

https://www.marketinsightsreports.com/reports/01162550863/blood-glucose-monitoring-systems-market-insights-competitive-landscape-and-market-forecast-2025?Mode=12

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please connect with our sales team (sales@marketinsightsreports.com).

Contact Us:

Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.